As expected, those taking semaglutide lost more weight than those in the placebo group
In some people, these medications slow the stomach too much, which can cause food to stay in the stomach longer and lead to nausea, vomiting, bloating and pain
Synaptic Systems, 226003, RRID: AB_2231974), anti-DsRed (rabbit, 1:1,000
The FDA has approved several GLP-1 receptor agonists for type 2 diabetes management and, in some cases, chronic weight management
It is important to distinguish between GLP-1 receptor agonist medications (such as semaglutide and liraglutide, which are licensed pharmaceutical treatments) and probiotic supplements marketed with claims about GLP-1 modulation
Patients with type 2 diabetes, prediabetes, cardiovascular risk factors, or metabolic dysfunction may benefit even at lower BMI thresholds, though evidence varies